A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.
May 23, 2016
1
57
A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.
Jul 30, 2011
1
0
The United States Patent and Trademark Office has reaffirmed the validity of four important patents in the field of RNA therapeutics.
Dec 12, 2011
0
0
The American Civil Liberties Union and the Public Patent Foundation have petitioned the U.S. Supreme Court to hear Association for Molecular Pathology v. U.S. Patent and Trademark Office, a case that challenges the validity ...
Dec 15, 2011
0
0
The United States Patent and Trademark Office (USPTO) has granted a patent to Hwang Woo-suk for the technology behind the controversial work he and his team did a decade ago—at the time it was announced that the team had ...
For centuries, Indian housewives have used homemade remedies based on cow's milk to cure constipation—but in 2009 Swiss giant Nestle applied for a patent to protect a similar product of its own.
Oct 14, 2012
0
0
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Mar 12, 2012
0
1
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...
Mar 5, 2013
3
0
Scientists in the city at the center of China's virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger ...
Feb 6, 2020
0
1
Today, the Association for Molecular Pathology (AMP) asked the U.S. Patent and Trademark Office (USPTO) to place a moratorium on the issuing of patents on human genes during testimony presented at an Agency hearing on genetic ...
Feb 16, 2012
0
0
